Applied Therapeutics Performance Analysis: GAAP EPS Exceeds Expectations Amid Revenue Miss
Wednesday, 6 March 2024, 12:31
Applied Therapeutics Financial Report Overview
Applied Therapeutics recently disclosed its latest financial results, generating a mix of reactions from investors and analysts.
Key Highlights:
- GAAP EPS: -$1.42 (beat by $0.02)
- Revenue: $10 million (misses by $0.67 million)
The company's strong EPS performance was overshadowed by revenue falling short, highlighting both areas of strength and concern.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.